New Tests

[Anonymous]

On Neogenomics’ last earnings conference call they repeatedly referred to several new proprietary tests, developed with the help of a strategic partner.

I realize this is not an investing forum, but as a small investor I thought, great! The specialized a/p sector is very competitive, and thought this was a great development and a way to further differentiate themselves.

Does anyone closer to this company know if this is going to happen?
The CEO said (of this partner) this technology would be “transformative” for Neo. Pretty lofty prose.

 

[Anonymous]

The new tests will cure cancer, not just help diagnose it. Just ask management.

 

[Anonymous]

The new tests will cure cancer, not just help diagnose it. Just ask management.

I did. They also mentioned something about balancing the federal budget and easing tension in the Middle East.

 

[Anonymous]

http://www.cancernetwork.com/conference-reports/asco2013/lung-cancer/content/article/10165/2145713

 

[Anonymous]

http://www.cancernetwork.com/conference-reports/asco2013/lung-cancer/content/article/10165/2145713

Wonder if a 'competitor' posted this?

 

[Anonymous]

what was the point of that link??

Those test are proprietary by PCR by another lab (predictive) so...........huh?

Is that an area you folks are trying to get into or something?